A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (Q665054)
From MaRDI portal
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity |
scientific article |
Statements
A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity (English)
0 references
5 March 2012
0 references
Bayesian design
0 references
treatment selection
0 references
